loadpatents
name:-0.018435001373291
name:-0.0064821243286133
name:-0.00052189826965332
Raghavan; Krishnaswamy Srinivas Patent Filings

Raghavan; Krishnaswamy Srinivas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Raghavan; Krishnaswamy Srinivas.The latest application filed is for "parenteral formulation for epothilone analogs".

Company Profile
0.7.12
  • Raghavan; Krishnaswamy Srinivas - Cranbury NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Parenteral Formulation For Epothilone Analogs
App 20150218179 - Bandyopadhyay; Rebanta ;   et al.
2015-08-06
Parenteral Formulation For Epothilone Analogs
App 20140107169 - Bandyopadhyay; Rebanta ;   et al.
2014-04-17
Parenteral formulation for epothilone analogs
Grant 8,632,788 - Bandyopadhyay , et al. January 21, 2
2014-01-21
Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound
Grant 8,252,821 - Chandran , et al. August 28, 2
2012-08-28
Bioavailable Capsule Compositions of Amorphous Alpha-(N-Sulfonamido)Acetamide Compound
App 20100260837 - Chandran; Sachin ;   et al.
2010-10-14
Parenteral Formulation For Epothilone Analogs
App 20090069393 - Bandyopadhyay; Rebanta ;   et al.
2009-03-12
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
Grant RE40,387 - Bandyopadhyay , et al. June 17, 2
2008-06-17
Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyr- imidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulations
App 20060128726 - Wang; Xuebao ;   et al.
2006-06-15
Parenteral formulation for epothilone analogs
Grant 7,022,330 - Bandyopadhyay , et al. April 4, 2
2006-04-04
Parenteral formulation for epothilone analogs
App 20060013836 - Bandyopadhyay; Rebanta ;   et al.
2006-01-19
Pharmaceutical compositions and methods of using taxane derivatives
App 20050054716 - Gogate, Uday Shankar ;   et al.
2005-03-10
Pharmaceutical compositions and methods of using taxane derivatives
App 20040122081 - Gogate, Uday Shankar ;   et al.
2004-06-24
Methods of administering epothilone analogs for the treatment of cancer
Grant 6,670,384 - Bandyopadhyay , et al. December 30, 2
2003-12-30
Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
App 20030220391 - Bogardus, Joseph Ballard ;   et al.
2003-11-27
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
Grant 6,576,651 - Bandyopadhyay , et al. June 10, 2
2003-06-10
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
App 20020177615 - Bandyopadhyay, Rebanta ;   et al.
2002-11-28
Methods of administering epothilone analogs for the treatment of cancer
App 20020169190 - Bandyopadhyay, Rebanta ;   et al.
2002-11-14
Parenteral formulation for epothilone analogs
App 20020143038 - Bandyopadhyay, Rebanta ;   et al.
2002-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed